| State | Closed |
| Type | Subsidiary |
| Parent Company | Zealand Pharma |
| Founded | 2006 |
| Website | valeritas.com |
| Cybersecurity rating | AMore |
Valeritas was founded in 2006
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Valeritas
Emmanuel Dulac
President and Chief Executive Officer
Matt Dallas
Senior Vice President and Chief Financial Officer
Adam Steensberg
Executive Vice President, Research & Development, and Chief Medical Officer
Frank Sanders
President of Zealand Pharma U.S.
Valeritas Financials and Metrics
Summary Metrics
Founding Date | 2006 |
Total Funding | $272 m |
Investors | Advanced Technology Ventures, Pitango Venture Capital, MPM Capital, CHL Medical Partners, ONSET Ventures, Abingworth |
Valeritas is a subsidiary of Zealand Pharma
Valeritas Cybersecurity Score
Valeritas Online and Social Media Presence
528 Twitter followers
Valeritas has 528 Twitter Followers. The number of followers has decreased 0.5% month over month and decreased 2.2% quarter over quarter
Valeritas's Trends
Valeritas News and Updates
April 02, 2020
Zealand Pharma completes the acquisition of Valeritas
Company announcement – No. 15 / 2020
Valeritas Frequently Asked Questions
When was Valeritas founded?
Valeritas was founded in 2006.
Who are Valeritas key executives?
Valeritas's key executives are Emmanuel Dulac, Matt Dallas and Adam Steensberg.
How many employees does Valeritas have?
Valeritas has 90 employees.
Who are Valeritas competitors?
Competitors of Valeritas include Genteel, Neurometrix and Reapplix.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies